Short answer
Revvity (RVTY) filed its Q2 2026 10-Q quarterly report on May 12, 2026 for the quarter ended Apr 5, 2026. Quarterly revenue was $711M (up 7.0% year over year) with net income of $41M.
Q2 2026 key financials · XBRL
- Revenue
- $711M
- +7.0% YoY
- Net income
- $41M
- −3.6% YoY
- Operating margin
- 10.7%
- EPS (diluted)
- $0.36
- +2.9% YoY
Source: XBRL data from the Revvity (RVTY) Q2 2026 10-Q on SEC EDGAR. USD.
Revvity Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $711.1M, up 7% YoY from $664.8M
- Diagnostics strongest segment, revenue $349.3M, up 8% YoY
- Gross margin 54.5% vs 56.5%; operating margin 10.7% vs 10.9% YoY
- Cash $860.3M; operating cash flow $125.9M vs $134.1M YoY
- Share repurchases $86.5M; tariff cost impact approximately $6M on gross margin
Risk Factors
- Government funding and regulatory uncertainty triggering more cautious customer spending on instrumentation and consumables
- $8.9B net intangible assets exposed to impairment from adverse business changes or weaker Life Sciences and Diagnostics growth
- Evolving AI regulation increasing potential cybersecurity, intellectual-property, privacy, and data-protection liability
- Trade barriers, tariffs, and conflicts in Ukraine and Iran threatening supply-chain continuity and customer demand
- Limited or single-source suppliers creating potential production delays, higher costs, or quality declines
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Revvity quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.